Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Gennaro Daniele, Laura Arenare, Giovanni Scambia, Carmela Pisano, Roberto Sorio, Enrico Breda, Sabino De Placido, Antonella Savarese, Gabriella Ferrandina, Francesco Raspagliesi, Pierluigi Benedetti Panici, Antonella Ferro, Anita Rimanti, Gennaro Cormio, Domenica Lorusso, Sabrina Chiara Cecere, Simona Scalone, Valentina Angela Marsico, Cinzia Cardalesi, Francesco CognettiVanda Salutari, Laura Attademo, Lorenzo Guizzaro, Clorinda Schettino, Maria Carmela Piccirillo, Francesco Perrone, Ciro Gallo, Sandro Pignata

Research output: Contribution to journalArticle

Abstract

Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.

Original languageEnglish
JournalGynecologic Oncology
DOIs
Publication statusPublished - 2019

    Fingerprint

Keywords

  • Chemotherapy-induced neutropenia
  • Cytotoxic dosing methods
  • Meta-analysis
  • Ovarian cancer
  • Prognostic factors
  • Retrospective-prospective design

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., ... Pignata, S. (2019). Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2019.04.012